Korro Bio, Inc. (KRRO)
9.44
+0.53
(+5.95%)
USD |
NASDAQ |
Oct 20, 16:00
9.44
0.00 (0.00%)
After-Hours: 05:45
Korro Bio Market Cap : 138.82M for Oct. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 20, 2026 | 138.82M |
| October 19, 2026 | 131.03M |
| October 16, 2026 | 124.85M |
| October 15, 2026 | 136.91M |
| October 14, 2026 | 130.59M |
| October 13, 2026 | 129.56M |
| October 12, 2026 | 137.79M |
| October 09, 2026 | 149.41M |
| October 08, 2026 | 155.59M |
| October 07, 2026 | 154.26M |
| October 06, 2026 | 143.53M |
| October 05, 2026 | 146.61M |
| October 02, 2026 | 141.76M |
| October 01, 2026 | 142.79M |
| September 30, 2026 | 145.73M |
| September 29, 2026 | 140.59M |
| September 28, 2026 | 139.85M |
| September 25, 2026 | 140.73M |
| September 24, 2026 | 140.73M |
| September 23, 2026 | 144.56M |
| September 22, 2026 | 152.06M |
| September 21, 2026 | 146.76M |
| September 18, 2026 | 147.35M |
| September 17, 2026 | 173.53M |
| September 16, 2026 | 203.38M |
| Date | Value |
|---|---|
| September 15, 2026 | 206.91M |
| September 14, 2026 | 204.11M |
| September 11, 2026 | 203.08M |
| September 10, 2026 | 192.06M |
| September 09, 2026 | 190.14M |
| September 08, 2026 | 198.67M |
| September 04, 2026 | 180.00M |
| September 03, 2026 | 170.88M |
| September 02, 2026 | 176.03M |
| September 01, 2026 | 180.00M |
| August 31, 2026 | 183.67M |
| August 28, 2026 | 189.85M |
| August 27, 2026 | 195.00M |
| August 26, 2026 | 201.17M |
| August 25, 2026 | 201.91M |
| August 24, 2026 | 192.20M |
| August 21, 2026 | 193.82M |
| August 20, 2026 | 190.58M |
| August 19, 2026 | 205.14M |
| August 18, 2026 | 194.41M |
| August 17, 2026 | 193.23M |
| August 14, 2026 | 195.29M |
| August 13, 2026 | 195.44M |
| August 12, 2026 | 196.32M |
| August 11, 2026 | 195.88M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.316B |
| Oncolytics Biotech, Inc. | 62.14M |
| Sangamo Therapeutics, Inc. | 45.57M |
| Sarepta Therapeutics, Inc. | 2.025B |
| Anixa Biosciences, Inc. | 92.69M |
Market Cap Related Metrics
| PS Ratio | 47.57 |
| PEG Ratio | -0.3599 |
| Price to Book Value | 1.345 |
| Price | 9.44 |
| Earnings Yield | -106.0% |
| PEGY Ratio | -0.3599 |